The global hyaluronic acid (HA) viscosupplementation market was valued at $2.5 billion in 2024 and is projected to grow at a CAGR of 2.9%, reaching $3 billion by 2031.
This market includes four primary product categories:
- Single Injection
- Two Injections
- Three Injections
- Five Injections
Market Insights & Data Coverage
- Unit Sales & Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Landscape, Mergers & Acquisitions
- Company Profiles & Product Portfolios
Market Trends
Impact of COVID-19 on Market Growth:
- The COVID-19 pandemic led to a temporary decline in sales due to postponements of elective procedures.
- By 2022, the market rebounded, returning to steady growth.
- Growing Prevalence of Osteoarthritis:
- Increased aging population and rising osteoarthritis cases are fueling demand for HA viscosupplementation.
- Shift Towards Single-Injection Therapies:
- Convenience and lower patient burden are driving single-injection adoption.
Market Share Insights
Top Competitors in the Global Hyaluronic Acid Viscosupplementation Market (2024):1 DePuy Synthes
- Market leader with its MONOVISC® (single-injection) and ORTHOVISC® (three-injection) products.
2 Fidia
- Second-largest market share with its HYMOVIS® (two-injection therapy).
3 Sanofi
- Third-largest competitor, offering Synvisc® and Synvisc-One®, benefiting from the growing osteoarthritis market.
Market Segmentation Summary
Hyaluronic Acid Viscosupplementation Market
- Single Injection Market
- Two Injections Market
- Three Injections Market
- Five Injections Market
Global Research Scope
- Regions Covered:
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
- Western Europe (Germany, France, U.K., Spain, Italy)
- Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
- Middle East (Saudi Arabia, UAE, Israel)
- Asia Pacific (China, Japan, India, South Korea, Australia)
- Africa (South Africa, Egypt, Nigeria, Kenya)
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size, Market Shares
- Market Forecasts, Growth Rates
- Units Sold, Average Selling Prices
- Procedure Numbers
Qualitative Coverage
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls, Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government Physician Data & Regulatory Data
- Hospital Private Data
- Import & Export Data
- Internal Database
Table of Contents
- Executive Summary
- Competitive Analysis
- Regions Included
- Introduction
- Benefits of Viscosupplementation
- Synovial Fluid
- Product Types
- Single-Injection Products
- Two-Injection Cycle Products
- Three-Injection Cycle Products
- Three-/Five-Injection Cycle Products
- Procedure Numbers
- Market Overview
- By Segment
- By Region
- Market Analysis and Forecast
- Total Hyaluronic Acid Viscosupplementation Market
- Single-Injection Hyaluronic Acid Viscosupplementation Market
- Two-Injection Hyaluronic Acid Viscosupplementation Market
- Three-Injection Hyaluronic Acid Viscosupplementation Market
- Five-Injection Hyaluronic Acid Viscosupplementation Market
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
- Hyaluronic Acid Viscosupplementation Market, Global, 2024 & 2031
- Hyaluronic Acid Viscosupplementation Procedures, Global, 2024
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 - 2031
- Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 - 2031
- Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 - 2031
- Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024
- Hyaluronic Acid Viscosupplementation Regions Covered, Global
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, North America, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Western Europe, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Middle East, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 - 2031
- Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Africa, 2021 - 2031
- Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 - 2031 (US$M)
- Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 - 2031 (US$M)
- Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Units Sold by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Average Selling Price by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
- Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Units Sold by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Average Selling Price by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
- Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Units Sold by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Average Selling Price by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
- Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Units Sold by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Average Selling Price by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
- Market Value by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
- Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Units Sold by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
- Average Selling Price by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021- 2031 (US$)
- Market Value by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
- Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie
- LCA Pharma
- Acumed
- LifeLink Tissue Bank
- AlloSource
- LifeNet Health
- Alphatec Spine
- Meda Pharma
- Anika Therapeutics
- Medtronic
- Arthrex
- MTF
- B. Braun Melsungen
- Novabone
- Baxter
- Nuo Therapeutics
- Berkeley Advanced Biomaterials
- Octane Medical
- Biocell
- Orthocell Ltd.
- Biocomposites
- OrthogenRx
- Biogennix
- Orthofix
- Bioiberica
- Osteogenics
- Biomatlante
- OsteoMed
- Biotissue Technologies
- Paragon 28
- Bioventus
- Plasmaconcept
- Bonalive
- PromoCell
- Celling Biosciences
- Rebone Biomaterials
- Cerapedics
- Recordati
- Cingal
- Regenexx
- Croma-Pharma
- Regenity Biosciences
- CO.DON GmbH
- RTI Surgical
- CONMED
- Sanofi
- Curasan
- Sartorius CellGenix GmbH
- DCI Donor Services
- Seikagaku
- DePuy Synthes
- Smith & Nephew
- Documedica
- Solvita
- Elutia Inc.
- Spinal Elements
- Exactech
- Stella Pharmaceuticals
- Ferring Pharmaceuticals
- Stryker
- Fidia
- Takara Bio
- Finceramica
- Tedec-Meiji
- Geistlich
- Terumo
- Globus Medical/NuVasive
- Teva Pharmaceutical
- Hanmi Pharmaceutical
- ThermoGenesis
- Healiva
- TRB Chemedica
- IBSA Pharma
- Viatris
- Integra LifeSciences
- Vericel
- Isto Biologics
- Vivex
- Kolon Tissuegene
- Xtant Medical
- Kuros
- Zimmer Biomet
